Serology Testing Market Opportunities, Business Forecast To 2029

The global serology testing market size was valued at USD 4,305.0 million in 2022 and is expected to grow at a CAGR of 14.0% during the forecast period 2023 to 2029. The primary drivers of the expansion of the global serology testing market include the increasing prevalence of infectious disease and increase in incidence of HIV/AIDS, Tuberculosis, hepatitis. Rising product launches by the market players is expected to boost the market growth over the forecasted period.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/serology-testing-market

Immunoglobin G Segment is expected to Dominate the Serology Testing Market
Based on the application, the global Serology Testing market is segmented into Rotavirus Infections, Hepatitis, HIV, Endotoxins, Therapeutic Drug Monitoring, Immunoglobin G, and Others. The immunoglobin G segment is expected to account for a larger revenue share in the global serology testing market. Immunoglobin G is most commonly used antibody test for infectious diseases. Immunoglobin G is used to detect the antibody produced by the body by immune response to any virus or bacteria attack or infection. Immunoglobin g is also used to detect the prior infections and immunity to certain disease.

Europe Serology Testing Market
The Europe serology testing market is expected to increase over the forecast period due to the increasing prevalence of chronic infectious diseases in this region. in addition, the presence of well-established healthcare infrastructure and increasing number of geriatric population in this region is expected to drive the growth of serology testing market in this region over the forecasted period. Furthermore, increasing cases of celiac disease in this region is expected to fuel the market growth in this region. additionally, product launches by the key market player in this region is expected to further fuel the growth of market in this region.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.

The global Serology Testing market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In April 2020, Accelerate Diagnostics and Biocheck collaborated to distribute SARS-COV-2 Antibody tests and MS-FAST Chemiluminescence Immunoassay Analyzer. In March 2020, Chembio Diagnostic Systems Inc launched their product 'DPP Covid-19 serological test kit'.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=155794

The Serology Testing market is segmented based on test type, application, technology, end user, and geography.
Based on the test type, the market is segmented into the following:
• Primary Serological Tests
• Secondary Serological Tests
• Tertiary Binding Tests

Based on the application, the market is segmented into the following:
• Rotavirus Infections
• Hepatitis
• HIV
• Endotoxins
• Therapeutic Drug Monitoring
• Immunoglobin G
• Others

Based on the technology, the market is segmented into the following:
• ELISA
• NAT
• CLIA/CMIA
• Others

Based on the end use industry, the market is segmented into the following:
• Hospital and Clinics
• Diagnostic Laboratories
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Key players profiles in the Serology Testing market report are F. Hoffmann La-Roche Ltd, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., ELI Tech Group, Becton, Dickinson and Company (BD), Abbott, Randox Laboratories Ltd., Quest Diagnostics, Serological Research Institute., Creative Diagnostics

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.